Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder Cancer.
Journal: European urology focus
Published: March 11, 2025
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review.
Journal: Clinical genitourinary cancer
Published: December 20, 2024
NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 08, 2024
Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 29, 2024
Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC): Current Guidance and Experience from Clinical Practice.
Journal: Research and reports in urology
Published: August 31, 2024
Repurposing Valrubicin as a Potent Inhibitor of Ovarian Cancer Cell Growth.
Journal: Anticancer research
Published: August 03, 2024
Comparative analysis of adverse events among intravesical drugs in bladder cancer: a real-world study on FAERS database.
Journal: Expert opinion on drug safety
Published: July 01, 2024
Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications.
Journal: Cancer letters
Published: June 04, 2024
Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma.
Journal: Frontiers in molecular biosciences
Published: April 29, 2024
Last Updated: 10/31/2025